Text Size

CMR Repeatability in STEMI

This study is currently recruiting participants.
Verified March 2012 by University of Bristol
Sponsor:
Information provided by (Responsible Party):
Elisa McAlindon, University of Bristol
ClinicalTrials.gov Identifier:
NCT01468662
First received: November 7, 2011
Last updated: March 9, 2012
Last verified: March 2012
History of Changes
  Purpose

The investigators propose to conduct a study to measure the reproducibility of CMR parameters that have been used to predict outcome following PPCI: infarct size, left ventricular volumes, myocardial salvage, microvascular obstruction (MVO) and myocardial oedema.


Condition
STEMI

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Cardiovascular Magnetic Resonance Scan Repeatability in ST Segment Elevation Myocardial Infarction

Resource links provided by NLM:

MedlinePlus related topics: Heart Attack
U.S. FDA Resources

Further study details as provided by University of Bristol:

Estimated Enrollment: 40
Study Start Date: November 2011

  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

ST segment elevation myocardial infarction

Criteria

Inclusion Criteria:

Participant may enter study if ALL of the following apply

  1. ST segment myocardial infarction as defined by ECG (by 2 contiguous limb leads with >1 mm ST-segment elevation, or >2 mm ST-segment elevation in contiguous precordial leads, or new LBBB) and > 20 minutes of cardiac chest pain
  2. Written informed consent

Exclusion Criteria:

Participant may not enter study if ANY of the following apply

  1. Contraindication to MRI (implanted pacemaker/ defibrillator, ferromagnetic metal implant/ injury, claustrophobia, obesity/ too large for CMR scanner)
  2. Known allergy to gadolinium
  3. Chronic atrial fibrillation
  4. Renal impairment with eGFR <30
  5. Cardiogenic shock
  6. Patients with special communication needs
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01468662

Contacts
Contact: Elisa McAlindon, BMBS elisa.mcalindon@bristol.ac.uk

Locations
United Kingdom
Bristol Heart Institute Recruiting
Bristol, United Kingdom, BS2 8HW
Contact: Elisa McAlindon, BMBS         elisa.mcalindon@bristol.ac.uk    
Sponsors and Collaborators
University of Bristol
Investigators
Principal Investigator: Elisa McAlindon, BMBS University of Bristol
  More Information

No publications provided

Responsible Party: Elisa McAlindon, Cardiology Clinical Research Fellow, University of Bristol
ClinicalTrials.gov Identifier: NCT01468662     History of Changes
Other Study ID Numbers: Study 1569
Study First Received: November 7, 2011
Last Updated: March 9, 2012
Health Authority: United Kingdom: Research Ethics Committee

Additional relevant MeSH terms:
Myocardial Infarction
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 23, 2013